Literature DB >> 8377912

Haemorrhage in intracerebral arteriovenous malformations: detection with MRI and comparison with clinical history.

L Prayer1, D Wimberger, R Stiglbauer, J Kramer, B Richling, G Bavinzski, T Czech, H Imhof.   

Abstract

Fifty-one patients with 59 angiographically proven cerebral arteriovenous malformations (AVMs) were examined by high-field MRI to detect blood breakdown products. Results were correlated with the history of intracranial bleeding. Evidence of previous episodes of haemorrhage was seen in 10 of 12 patients (83.3%) with verified bleeding, in 4 of 9 patients (44.4%) with symptoms which could suggest bleeding and in 6 of 30 patients (20%) with negative histories. Because of the known rebleeding rate and the increased risk of associated complications, identification of the subgroup who had had haemorrhage and should therefore be considered for surgery may be beneficial. MRI can make a contribution to management by demonstrating prior haemorrhage in patients with an inadequate clinical history.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377912     DOI: 10.1007/bf00602821

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  MR imaging in the management of supratentorial intracranial AVMs.

Authors:  H J Smith; C M Strother; Y Kikuchi; T Duff; L Ramirez; A Merless; S Toutant
Journal:  AJR Am J Roentgenol       Date:  1988-05       Impact factor: 3.959

2.  The natural history of unruptured intracranial arteriovenous malformations.

Authors:  R D Brown; D O Wiebers; G Forbes; W M O'Fallon; D G Piepgras; W R Marsh; R J Maciunas
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

3.  Comparison of MR imaging with clinical history in the identification of hemorrhage in patients with cerebral arteriovenous malformations.

Authors:  D M Yousem; E S Flamm; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  1989 Nov-Dec       Impact factor: 3.825

4.  Bleeding from cerebral arteriovenous malformations as part of their natural history.

Authors:  C J Graf; G E Perret; J C Torner
Journal:  J Neurosurg       Date:  1983-03       Impact factor: 5.115

5.  Natural history of arteriovenous malformations of the brain: a clinical study.

Authors:  D Fults; D L Kelly
Journal:  Neurosurgery       Date:  1984-11       Impact factor: 4.654

6.  Cerebral arteriovenous malformations. Indications for and results of surgery, and the role of intravascular techniques.

Authors:  A J Luessenhop; L Rosa
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

7.  Intracranial arteriovenous malformations. Conservative and surgical treatment.

Authors:  B Guidetti; A Delitala
Journal:  J Neurosurg       Date:  1980-08       Impact factor: 5.115

8.  Arteriovenous malformations of the brain: natural history in unoperated patients.

Authors:  P M Crawford; C R West; D W Chadwick; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

9.  Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications.

Authors:  S W Atlas; A S Mark; R I Grossman; J M Gomori
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

10.  Treatment of unruptured cerebral arteriovenous malformations.

Authors:  M J Aminoff
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

View more
  6 in total

1.  Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture.

Authors:  Yi Guo; Tara Saunders; Hua Su; Helen Kim; Deniz Akkoc; David A Saloner; Steven W Hetts; Christopher Hess; Michael T Lawton; Andrew W Bollen; Tony Pourmohamad; Charles E McCulloch; Tarik Tihan; William L Young
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

2.  Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation.

Authors:  Yi Guo; Tarik Tihan; Helen Kim; Christopher Hess; Michael T Lawton; William L Young; Yuanli Zhao; Hua Su
Journal:  Neuroimmunol Neuroinflamm       Date:  2014

3.  Silent arteriovenous malformation hemorrhage and the recognition of "unruptured" arteriovenous malformation patients who benefit from surgical intervention.

Authors:  Adib A Abla; Jeffrey Nelson; Helen Kim; Christopher P Hess; Tarik Tihan; Michael T Lawton
Journal:  Neurosurgery       Date:  2015-05       Impact factor: 4.654

4.  Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.

Authors:  Wanqiu Chen; Yi Guo; Espen J Walker; Fanxia Shen; Kristine Jun; S Paul Oh; Vincent Degos; Michael T Lawton; Tarik Tihan; Dimitrios Davalos; Katerina Akassoglou; Jeffrey Nelson; John Pile-Spellman; Hua Su; William L Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

5.  The Role of Macrophage in the Pathogenesis of Brain Arteriovenous Malformation.

Authors:  Li Ma; Yi Guo; Yuan-Li Zhao; Hua Su
Journal:  Int J Hematol Res       Date:  2015-07-06

6.  NMR investigation of experimental chemical induced brain tumors in rats, potential of a superparamagnetic contrast agent (MD3) to improve diagnosis.

Authors:  V Rousseau; D Pouliquen; F Darcel; P Jallet; J J Le Jeune
Journal:  MAGMA       Date:  1998-08       Impact factor: 2.533

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.